Prof. Andreas Engert
Executive Steering Committee Member
University Hospital of Cologne
Andreas Engert M.D. is Professor for Internal Medicine, Hematology and Oncology at the University Hospital of Cologne.
Prof. Engert received his medical degree at the University of Hannover where he also carried out his medical training, as well as at the University Hospital of Cologne. Between 1988 and 1990 he worked at the Imperial Cancer Research Fund in London on new immunotherapeutic approaches for cancer.
Following his return to Cologne, Prof. Engert established a clinical-scientific Phase I/II programto focus on developing antibody-based immunotherapy for patients with malignant lymphoma resulting in a number of experimental phase I/II clinical trials.
He then finished his postdoctoral lecture qualification in 1995, and shortly afterwards was appointed consultant and became head of staff 1996. He was then chosen as coordinating editor of the Cochrane Hematological Malignancies Group (CHMG) and vice director of the Department for Hematology and Oncology in 2000. After Serving as Secretary of the German Hodgkin Study Group (GHSG) since 1999, Prof. Engert was elected GHSG chairman in 2007.
The focus of his research has been the development of targeted therapy to combat malignancy. Activities include constructs such as bispecific monoclonal antibodies, radioimmunoconjugates, humanized antibodies or immunoligands for diseases such as neuroblastoma, CLL, acute leukemias and malignant lymphoma. Prof. Engert treats patients with all malignancies and consults for lymphoma patients.
Positions of resposibility/awards:
- Honorary Doctorate of the University of Belgrade, Serbia (May 2012)
- Councilor to the EHA Board of Directors (June 2012)
- Member of the EHA Executive Board (June 2015)
- More than 400 original papers in peer-reviewed journals (N.Engl. J. Med, Lancet Oncology, J.Clin. Oncol., Nature Genetics and more)
- Ludwig-Heilmeyer Medal
- Arthur-Pappenheim Award
- Research Award of the University of Cologne
- Prize of the German Cancer Society 2011